Literature DB >> 2698963

Captopril and ramiprilat protect against free radical injury in isolated working rat hearts.

X J Pi1, X Chen.   

Abstract

The protection of angiotensin converting enzyme (ACE) inhibitors, captopril and ramiprilat, against free radical-mediated myocardial injury were studied in isolated working rat hearts. Free radicals were generated by electrolysis of Krebs-Henseleit solution with 10 mA direct current for 1 min. Both captopril (360 mumol/l) and ramiprilat (12.5 mumol/l) significantly reduced the decrease of left ventricle dP/dt'max, coronary flow (CF), myocardial superoxide dismutase (SOD) and creatine kinase (CK) activities and the elevation of S-T segment of epicardial ECG as well as the rise of myocardial malondialdehyde (MDA) content caused by electrolysed perfusate. Captopril afforded a dose-dependent protection on cardiac functions with various concentrations of 45, 90, 180 and 360 mumol/l. Iloprost (30 nmol/l), a stable mimetic of prostacyclin, could also alleviate free radical-mediated myocardial injuries. All the beneficial effects of ramiprilat (12.5 mumol/l) were abolished by the administration of indomethacin (5 mumol). In contrast, captopril (90 mumol/l) still exhibited significant protective effects after indomethacin (9 mumol) was administered, though these protective effects were insignificantly weakened. In order to assess the role of sulfhydryl (-SH) group in the effects of captopril, a SH-containing drug S8 and a disulfide DG4, both are deficient in ACE inhibitory properties in vitro, were examined. Data showed that S8 (180 mumol/l) provided a significant protection while DG4 showed no protective effect. It is concluded that ACE inhibitors can protect against free radical-induced myocardial damage. Ramiprilat, a non-SH-containing ACE inhibitor, inhibits free radical-induced damages mainly by stimulation of prostacyclin synthesis and/or release. In addition to this effect, captopril, a SH-containing ACE inhibitor, may exert additional anti-free radical effects by a mechanism which is probably related to the sulfhydryl group.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2698963     DOI: 10.1016/0022-2828(89)90672-x

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  12 in total

1.  Beneficial effect of beraprost, a prostacyclin-mimetic agent, on post-hypoxic recovery of cardiac function and metabolism in rabbit isolated hearts.

Authors:  K Tanonaka; Y Maruyama; S Takeo
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

Review 2.  Influence of ACE inhibitors on free radicals and reperfusion injury: pharmacological curiosity or therapeutic hope?

Authors:  J McMurray; M Chopra
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

Review 3.  Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease.

Authors:  R Ferrari; C Ceconi; S Curello; P Pepi; A Mazzoletti; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

4.  Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts.

Authors:  Imene Tabbi-Anneni; Jonathan Buchanan; Robert C Cooksey; E Dale Abel
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

5.  Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury.

Authors:  H Suzuki; A Matsumori; Y Matoba; B S Kyu; A Tanaka; J Fujita; S Sasayama
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

6.  The effect of angiotensin-converting enzyme inhibitors on human neutrophil chemotaxis in vitro.

Authors:  M Clapperton; J McMurray; A C Fisher; H J Dargie
Journal:  Br J Clin Pharmacol       Date:  1994-07       Impact factor: 4.335

7.  Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta.

Authors:  S Mittra; M Singh
Journal:  Mol Cell Biochem       Date:  1998-06       Impact factor: 3.396

Review 8.  Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease.

Authors:  G L Plosker; D McTavish
Journal:  Drugs Aging       Date:  1995-09       Impact factor: 3.923

9.  Evidence for norepinephrine cardiotoxicity mediated by superoxide anion radicals in isolated rabbit hearts.

Authors:  A F Rump; W Klaus
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

Review 10.  Pharmacokinetic optimisation of angiotensin converting enzyme (ACE) inhibitor therapy.

Authors:  M Burnier; J Biollaz
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.